Investigation of the Performance of Ostomy Base Plate

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the performance of Atlas (new base plate) on the degree of leakage under the base plate compared to SenSura and Conform 2. Our hypothesis is that Atlas will do better than the two comparator products.

Clinical Trial Description

Peristomal skin problems are reported to have a negative impact on the quality of life of people with a stoma and cause one third of all visits to a stoma care nurse. Stoma effluent in contact with the peristomal skin (leakage) appears to predispose patients to peristomal skin problems. To protect the skin against effluent, the appliance used for collection of stoma effluent should completely cover the peristomal skin close to the stoma. Coloplast has developed a new base plate (SSH) to improve security and increase comfort by minimizing leakage (seeping under the base plate) risk and thereby also the leakage related peristomal skin problems.

The purpose with this clinical study is to evaluate the effect of the new base plate on the degree of leakage under the base plate compared to two existing base plates on the market.

The study is a randomised controlled cross-over intervention study, where all study participants will test all three test products (SSH, Conform 2 and Sensura). Each test period will last 14 days. If 4 changes of base plates is not obtained during the 14 days, the test period will be prolonged until 4 base plate changes is obtained. However, the max test period of one type of product is 21 days. The participants will visit the study investigator at study start and at every shift to a new type of test product. At these visits they will answer questions about the tested product, have a peristomal skin examination and be instructed in how to use the next test products for the next treatment period. Evaluation of leakage and handling will occur via questionnaires the participants take home.

80 healthy participants with an ileostomy will be included in the study. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Ileostomy - Stoma

Clinical Trial Details

NCT number	NCT01103466
Study type	Interventional
Source	Coloplast A/S
Contact
Status	Completed
Phase	N/A
Start date	April 2010
Completion date	December 2010

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03746353` - Early Closure Versus Conventional Closure in Postoperative Patients With Low Anteriresection for Rectal Cancer	N/A
Completed	`NCT03331783` - Assessment of the Effect of Output on New Adhesives	N/A
Completed	`NCT02886455` - Evaluation of the Influence of Output on Skin Covered by Newly Developed Adhesives	N/A
Completed	`NCT02920294` - Modulation of Microbial Composition in Ileostomy Patients	N/A
Completed	`NCT02517541` - A Clinical Investigation Evaluating and Understanding Parameters Affecting the Performance of Ostomy Products	N/A
Completed	`NCT01957553` - Investigating the Safety and Performance of a New 2-piece Ostomy Product Compared With SenSura Click 2-piece	N/A
Completed	`NCT01939600` - Digestibility of Selected Resistant Starches in Humans	N/A
Completed	`NCT01994876` - Investigation of Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy	N/A
Terminated	`NCT01994863` - Safety and Performance Investigation of a New 1-piece Ostomy Product Compared to Standard of Care 1-piece in Subjects With Ileostomy	Phase 2
Completed	`NCT03289013` - Assessement of the Peal Force Needed to Peel New Adhesives From the Skin	N/A
Terminated	`NCT03416023` - Safety, Performance and Durability of the TIES® Implant in Patients Requiring a Permanent Ileostomy	N/A
Completed	`NCT02997267` - Early Closure of Protective Ileostomy in Rectal Cancer Patients	N/A
Recruiting	`NCT01880918` - A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing	N/A
Completed	`NCT01957397` - Investigation of Three Newly Developed 2-piece Convex Base-plates in Subjects With Ileostomy	N/A
Recruiting	`NCT04577456` - Chyme Reinfusion for Type 2 Intestinal Failure	N/A
Terminated	`NCT03587519` - Short Versus Long Interval to Ileostomy Reversal After Ileal Pouch Surgery	N/A
Recruiting	`NCT03872271` - Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL Trial	N/A
Completed	`NCT04606004` - Perianal Maceration in Pediatric Ostomy Closure Patients	N/A
Completed	`NCT02886403` - Evaluation of the Influence of Output on a Newly Develop Adhesive	N/A
Recruiting	`NCT03424447` - Stimulation of the Efferent Loop Before Loop Ileostomy Closure	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.